 | • レポートコード：TPM-B04455 • 出版社/出版日：Transparency Market Research / 2018年1月 • レポート形態：英文、PDF、200ページ • 納品方法：Eメール • 産業分類：製薬・医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、スポーツ医学における局所疼痛管理治療薬の世界市場について調べ、スポーツ医学における局所疼痛管理治療薬の世界規模、市場動向、市場環境、製品別分析、治療クラス別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・スポーツ医学における局所疼痛管理治療薬の世界市場動向 ・スポーツ医学における局所疼痛管理治療薬の世界市場環境 ・スポーツ医学における局所疼痛管理治療薬の世界市場規模 ・スポーツ医学における局所疼痛管理治療薬の世界市場規模：製品別 ・スポーツ医学における局所疼痛管理治療薬の世界市場規模：治療クラス別 ・スポーツ医学における局所疼痛管理治療薬の世界市場：地域別市場規模・分析 ・スポーツ医学における局所疼痛管理治療薬の北米市場規模・予測 ・スポーツ医学における局所疼痛管理治療薬のアメリカ市場規模・予測 ・スポーツ医学における局所疼痛管理治療薬の中南米市場規模・予測 ・スポーツ医学における局所疼痛管理治療薬のヨーロッパ市場規模・予測 ・スポーツ医学における局所疼痛管理治療薬のアジア市場規模・予測 ・スポーツ医学における局所疼痛管理治療薬の日本市場規模・予測 ・スポーツ医学における局所疼痛管理治療薬の中国市場規模・予測 ・スポーツ医学における局所疼痛管理治療薬のインド市場規模・予測 ・スポーツ医学における局所疼痛管理治療薬の中東市場規模・予測 ・スポーツ医学における局所疼痛管理治療薬のアフリカ市場規模・予測 ・競争状況・関連企業情報 |
Global Topical Pain Management Therapeutics in Sports Medicine Market: Scope and Methodology
This report on the global topical pain management therapeutics in sports medicine market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.
The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment and sub-segment for the period from 2017 to 2025, considering the macro and micro environmental factors. Growth rates for each segment within the global topical pain management therapeutics in sports medicine market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.
A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global topical pain management therapeutics in sports medicine Market.
Market revenue in terms of US$ Mn for the period between 2015 and 2025 along with the compound annual growth rate (CAGR %) from 2017 to 2025 are provided for all the segments, considering 2016 as the base year. Market size estimations involved in-depth study of product features of different types of products. Additionally, market related factors such as rise in preference for topical therapeutics, rising sports injuries, projected launch of the products etc. in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.
Topical Pain Management Therapeutics in Sports Medicine Market: Segmentation
Topical pain management therapeutics are specialty products that are used to relieve acute musculoskeletal pain or general sprains or strains. The therapeutics involve various drug classes such as analgesics, anesthetics, and skeletal muscle relaxants.
Based on product, the global topical pain management therapeutics in sports medicine market has been segmented into gels, cream, sprays and patches. The patches segment is further segmented into drugs in adhesives, matrix, reservoirs and others. The gel segment is anticipated to hold a significant share of the global market. The segment is projected to dominate the market during the forecast period due to the local players offering cost effective novel gel formulation.
Based on therapeutic class, the global topical pain management therapeutics in sports medicine market is segmented into analgesics, anesthetics and skeletal muscle relaxants. The analgesics segment is further divided into opioids and non-opioids. The opioids are further classified into fentanyl, buprenorphine and others, while the no-opioids are further segmented into lidocaine, diclofenac, capsaicin, methyl salicylate and others. The analgesics segment is anticipated to dominate the global market throughout the forecast period owing to shift of patient preference from oral drugs to topical analgesics.
Topical Pain Management Therapeutics in Sports Medicine Market: Geographical and Competitive Dynamics
Geographically, the global topical pain management therapeutics in sports medicine market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In addition, the regions have been further segmented by major countries from each region.
The report also profiles major players in the topical pain management therapeutics in sports medicine market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Hisamitsu Pharmaceutical Co., Inc., Mayne Pharma Group Limited, Sanofi (Chattem, Inc.), GlaxoSmithKline plc, Endo Pharmaceuticals Inc., Beiersdorf AG, Johnson & Johnson Services, Inc., and Topical BioMedics, Inc.
The global topical pain management therapeutics in sports medicine market has been segmented as follows:
Global Topical Pain Management Therapeutics in Sports Medicine Market, by Product
Gels
Creams
Sprays
Patches
Drug in Adhesives
Matrix
Reservoirs
Others
Global Topical Pain Management Therapeutics in Sports Medicine Market, by Therapeutic Class
Analgesics
Opioids
Fentanyl
Buprenorphine
Others
Non-opioids
Lidocaine
Diclofenac
Capsaicin
Methyl Salicylate
Others
Anesthetics
Skeletal Muscle Relaxants
Global Topical Pain Management Therapeutics in Sports Medicine Market, by Geography
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
Rest of APAC
Latin America
Brazil
Mexico
Rest of LATAM
Middle East & Africa
GCC Countries
South Africa
Rest of MEA
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Topical Pain Management Therapeutics in Sports Medicine Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.1.1. Increasing incidence of musculoskeletal acute sports injuries.
4.3.1.2. Guidelines implemented by various healthcare organizations promoting use of topical medications over oral medications in pain management
4.3.1.3. Innovative product launches, such as fast-relief liquid gel formulations, by market players leading to growing demand
4.3.2. Restraints
4.3.2.1. Growing patient preference for pain management devices in treatment of sports injuries
4.3.3. Opportunity
4.4. Global Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecasts, 2015–2025
4.5. Porter’s Five Force Analysis
4.6. Market Outlook
4.7. WHO Pain Relief Ladder
4.8. Patch Design Technologies: Snapshot
4.9. Snapshot: Topical Pain Management Therapeutics in Sport Industry – by Prescription and OTC products; 2016
5. Global Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecasts, By Product
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Market Value Forecast By Product, 2015–2025
5.3.1. Gel
5.3.2. Creams
5.3.3. Sprays
5.3.4. Patches
5.3.4.1. Drug in Adhesives
5.3.4.2. Matrix
5.3.4.3. Reservoirs
5.3.4.4. Others
5.4. Market Attractiveness By Product
6. Global Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecasts, By Therapeutic Class
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Therapeutic Class, 2015–2025
6.3.1. Analgesics
6.3.1.1. Opioids
6.3.1.1.1. Fentanyl
6.3.1.1.2. Buprenorphine
6.3.1.1.3. Others
6.3.1.2. Non-opioids
6.3.1.2.1. Lidocaine
6.3.1.2.2. Diclofenac
6.3.1.2.3. Capsaicin
6.3.1.2.4. Methyl Salicylate
6.3.1.2.5. Others
6.3.2. Anesthetics
6.3.3. Skeletal Muscle Relaxants
6.4. Market Attractiveness By Therapeutic Class
7. Global Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecasts, By Region
7.1. Key Findings
7.2. Market Value Forecast By Region
7.2.1. North America
7.2.2. Europe
7.2.3. Asia Pacific
7.2.4. Latin America
7.2.5. Middle East & Africa
7.3. Market Attractiveness By Region
8. North America Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecast
8.1. Introduction
8.1.1. Key Findings
8.2. Market Value Forecast By Product, 2015–2025
8.2.1. Gel
8.2.2. Creams
8.2.3. Sprays
8.2.4. Patches
8.2.4.1. Drug in Adhesives
8.2.4.2. Matrix
8.2.4.3. Reservoirs
8.2.4.4. Others
8.3. Market Value Forecast By Therapeutic Class, 2015–2025
8.3.1. Analgesics
8.3.1.1. Opioids
8.3.1.1.1. Fentanyl
8.3.1.1.2. Buprenorphine
8.3.1.1.3. Others
8.3.1.2. Non-opioids
8.3.1.2.1. Lidocaine
8.3.1.2.2. Diclofenac
8.3.1.2.3. Capsaicin
8.3.1.2.4. Methyl Salicylate
8.3.1.2.5. Others
8.3.2. Anesthetics
8.3.3. Skeletal Muscle Relaxants
8.4. Market Value Forecast By Country, 2015–2025
8.4.1. U.S.
8.4.2. Canada
8.5. Market Attractiveness Analysis
8.5.1. By Product
8.5.2. By Therapeutic Class
8.5.3. By Country
9. Europe Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast By Product, 2015–2025
9.2.1. Gel
9.2.2. Creams
9.2.3. Sprays
9.2.4. Patches
9.2.4.1. Drug in Adhesives
9.2.4.2. Matrix
9.2.4.3. Reservoirs
9.2.4.4. Others
9.3. Market Value Forecast By Therapeutic Class, 2015–2025
9.3.1. Analgesics
9.3.1.1. Opioids
9.3.1.1.1. Fentanyl
9.3.1.1.2. Buprenorphine
9.3.1.1.3. Others
9.3.1.2. Non-opioids
9.3.1.2.1. Lidocaine
9.3.1.2.2. Diclofenac
9.3.1.2.3. Capsaicin
9.3.1.2.4. Methyl Salicylate
9.3.1.2.5. Others
9.3.2. Anesthetics
9.3.3. Skeletal Muscle Relaxants
9.4. Market Value Forecast By Country / Sub-region, 2015–2025
9.4.1. Germany
9.4.2. U.K.
9.4.3. France
9.4.4. Spain
9.4.5. Italy
9.4.6. Russia
9.4.7. Rest of Europe
9.5. Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By Therapeutic Class
9.5.3. By Country / Sub-region
10. Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Product, 2015–2025
10.2.1. Gel
10.2.2. Creams
10.2.3. Sprays
10.2.4. Patches
10.2.4.1. Drug in Adhesives
10.2.4.2. Matrix
10.2.4.3. Reservoirs
10.2.4.4. Others
10.3. Market Value Forecast By Therapeutic Class, 2015–2025
10.3.1. Analgesics
10.3.1.1. Opioids
10.3.1.1.1. Fentanyl
10.3.1.1.2. Buprenorphine
10.3.1.1.3. Others
10.3.1.2. Non-opioids
10.3.1.2.1. Lidocaine
10.3.1.2.2. Diclofenac
10.3.1.2.3. Capsaicin
10.3.1.2.4. Methyl Salicylate
10.3.1.2.5. Others
10.3.2. Anesthetics
10.3.3. Skeletal Muscle Relaxants
10.4. Market Value Forecast By Country / Sub-region, 2015–2025
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. Australia & New Zealand
10.4.5. Rest of Asia Pacific
10.5. Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By Therapeutic Class
10.5.3. By Country / Sub-region
11. Latin America Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Product, 2015–2025
11.2.1. Gel
11.2.2. Creams
11.2.3. Sprays
11.2.4. Patches
11.2.4.1. Drug in Adhesives
11.2.4.2. Matrix
11.2.4.3. Reservoirs
11.2.4.4. Others
11.3. Market Value Forecast By Therapeutic Class, 2015–2025
11.3.1. Analgesics
11.3.1.1. Opioids
11.3.1.1.1. Fentanyl
11.3.1.1.2. Buprenorphine
11.3.1.1.3. Others
11.3.1.2. Non-opioids
11.3.1.2.1. Lidocaine
11.3.1.2.2. Diclofenac
11.3.1.2.3. Capsaicin
11.3.1.2.4. Methyl Salicylate
11.3.1.2.5. Others
11.3.2. Anesthetics
11.3.3. Skeletal Muscle Relaxants
11.4. Market Value Forecast By Country / Sub-region, 2015–2025
11.4.1. Brazil
11.4.2. Mexico
11.4.3. Rest of Latin America
11.5. Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By Therapeutic Class
11.5.3. By Country / Sub-region
12. Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Product, 2015–2025
12.2.1. Gel
12.2.2. Creams
12.2.3. Sprays
12.2.4. Patches
12.2.4.1. Drug in Adhesives
12.2.4.2. Matrix
12.2.4.3. Reservoirs
12.2.4.4. Others
12.3. Market Value Forecast By Therapeutic Class, 2015–2025
12.3.1. Analgesics
12.3.1.1. Opioids
12.3.1.1.1. Fentanyl
12.3.1.1.2. Buprenorphine
12.3.1.1.3. Others
12.3.1.2. Non-opioids
12.3.1.2.1. Lidocaine
12.3.1.2.2. Diclofenac
12.3.1.2.3. Capsaicin
12.3.1.2.4. Methyl Salicylate
12.3.1.2.5. Others
12.3.2. Anesthetics
12.3.3. Skeletal Muscle Relaxants
12.4. Market Value Forecast By Country / Sub-region, 2015–2025
12.4.1. GCC Countries
12.4.2. South Africa
12.4.3. Rest of Middle East & Africa
12.5. Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By Therapeutic Class
12.5.3. By Country / Sub-region
13. Competition Landscape
13.1. Market Player – Competition Matrix (By Tier and Size of companies)
13.2. Market Share Analysis By Company (2016)
13.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
13.3.1. Beiersdorf AG
13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.1.2. Product Portfolio
13.3.1.3. SWOT Analysis
13.3.1.4. Financial Overview
13.3.1.5. Strategic Overview
13.3.2. Endo Pharmaceuticals Inc.
13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.2.2. Product Portfolio
13.3.2.3. SWOT Analysis
13.3.2.4. Financial Overview
13.3.2.5. Strategic Overview
13.3.3. GlaxoSmithKline plc.
13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.3.2. Product Portfolio
13.3.3.3. SWOT Analysis
13.3.3.4. Financial Overview
13.3.3.5. Strategic Overview
13.3.4. Hisamitsu Pharmaceutical Co.,Inc.
13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.4.2. Product Portfolio
13.3.4.3. SWOT Analysis
13.3.4.4. Financial Overview
13.3.4.5. Strategic Overview
13.3.5. Johnson & Johnson Services, Inc.
13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.5.2. Product Portfolio
13.3.5.3. SWOT Analysis
13.3.5.4. Financial Overview
13.3.5.5. Strategic Overview
13.3.6. Mayne Pharma Group Limited
13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.6.2. Product Portfolio
13.3.6.3. SWOT Analysis
13.3.6.4. Financial Overview
13.3.6.5. Strategic Overview
13.3.7. Pfizer Inc.
13.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.7.2. Product Portfolio
13.3.7.3. SWOT Analysis
13.3.7.4. Financial Overview
13.3.7.5. Strategic Overview
13.3.8. Sanofi (Chattem, Inc. )
13.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.8.2. Product Portfolio
13.3.8.3. SWOT Analysis
13.3.8.4. Financial Overview
13.3.8.5. Strategic Overview
13.3.9. Teva Pharmaceutical Industries Limited
13.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.9.2. Product Portfolio
13.3.9.3. SWOT Analysis
13.3.9.4. Financial Overview
13.3.9.5. Strategic Overview
13.3.10. Topical BioMedics, Inc.
13.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.10.2. Product Portfolio
13.3.10.3. SWOT Analysis
13.3.10.4. Financial Overview
13.3.10.5. Strategic Overview
Table 01: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Product, 2015–2025
Table 02: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Patches, 2015–2025
Table 03: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2015–2025
Table 04: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Analgesic Therapeutic Class, 2015–2025
Table 05: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Opioid Analgesic Therapeutic Class, 2015–2025
Table 06: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Non-opioid Analgesic Therapeutic Class, 2015–2025
Table 07: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Region, 2015–2025
Table 08: North America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Country, 2015–2025
Table 09: North America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Product, 2015–2025
Table 10: North America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Patches, 2015–2025
Table 11: North America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2015–2025
Table 12: North America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Analgesic Therapeutic Class, 2015–2025
Table 13: North America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Opioid Analgesic Therapeutic Class, 2015–2025
Table 14: North America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Non-opioid Analgesic Therapeutic Class, 2015–2025
Table 15: Europe Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Country, 2015–2025
Table 16: Europe Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Product, 2015–2025
Table 17: Europe Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Patches, 2015–2025
Table 18: Europe Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2015–2025
Table 19: Europe Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Analgesic Therapeutic Class, 2015–2025
Table 20: Europe Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Opioid Analgesic Therapeutic Class, 2015–2025
Table 21: Europe Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Non-opioid Analgesic Therapeutic Class, 2015–2025
Table 22: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Country, 2015–2025
Table 23: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Product, 2015–2025
Table 24: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Patches, 2015–2025
Table 25: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2015–2025
Table 26: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Analgesic Therapeutic Class, 2015–2025
Table 27: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Opioid Analgesic Therapeutic Class, 2015–2025
Table 28: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Non-opioid Analgesic Therapeutic Class, 2015–2025
Table 29: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Country, 2015–2025
Table 30: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Product, 2015–2025
Table 31: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Patches, 2015–2025
Table 32: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2015–2025
Table 33: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Analgesic Therapeutic Class, 2015–2025
Table 34: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Opioid Analgesic Therapeutic Class, 2015–2025
Table 35: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Non-opioid Analgesic Therapeutic Class, 2015–2025
Table 36: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Country, 2015–2025
Table 37: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Product, 2015–2025
Table 38: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Patches, 2015–2025
Table 39: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2015–2025
Table 40: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Analgesic Therapeutic Class, 2015–2025
Table 41: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Opioid Analgesic Therapeutic Class, 2015–2025
Table 42: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Non-opioid Analgesic Therapeutic Class, 2015–2025